A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours

Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus

(2013) Pedro Weslley Rosário et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma

(2012) Lucas L. Cunha et al.   CLINICAL ENDOCRINOLOGY

Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas

(2012) LL Cunha et al.   Clinics

Thyroid Cancer Survival in the United States

(2010) Louise Davies et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18 000 FNAs reported at the same institution during 1998-2007

(2010) S. Piana et al.   CYTOPATHOLOGY

Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination

(2009) S. Guth et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Generation of Monoclonal Antibody Targeting Fibroblast Growth Factor Receptor 3

(2009) Olena Gorbenko et al.   HYBRIDOMA

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

(2009) Martin Schwickart et al.   NATURE

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

International patterns and trends in thyroid cancer incidence, 1973–2002

(2008) Briseis A. Kilfoy et al.   CANCER CAUSES & CONTROL

An Entirely Cell-Based System to Generate Single-Chain Antibodies against Cell Surface Receptors

(2008) Barbara D. Lipes et al.   JOURNAL OF MOLECULAR BIOLOGY